Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation

Clinical Research in Cardiology

Volumn 100, Issue 9, 2011, Pages 765-771

  Diehl, Philipp ^a   Halscheid, Christoph ^a   Olivier, Christoph ^a   Helbing, Thomas ^a   Bode, Christoph ^a   Moser, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Clopidogrel; P2Y 12; Platelet aggregation; Rebound hyperaggregability; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; LONG TERM CARE; MALE; REBOUND; STENT THROMBOSIS; THROMBOCYTE AGGREGATION;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; STENTS; THROMBOSIS; TICLOPIDINE; TIME FACTORS;

EID: 80054756391     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0310-7     Document Type: Article

References (29)

1. F Airoldi A Colombo N Morici A Latib J Cosgrave L Buellesfeld E Bonizzoni M Carlino U Gerckens C Godino G Melzi I Michev M Montorfano GM Sangiorgi A Qasim A Chieffo C Briguori E Grube 2007 Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 745 754 17664375 10.1161/CIRCULATIONAHA.106.686048 1:CAS:528:DC%2BD2sXos1agu78%3D (Pubitemid 47255992)
2. P Buonamici R Marcucci A Migliorini GF Gensini A Santini R Paniccia G Moschi AM Gori R Abbate D Antoniucci 2007 Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis J Am Coll Cardiol 49 2312 2317 17572245 10.1016/j.jacc.2007.01.094 1:CAS:528:DC%2BD2sXmsFKmu7o%3D (Pubitemid 46891710)
3. DE Cutlip DS Baim KK Ho JJ Popma AJ Lansky DJ Cohen JP Carrozza Jr MS Chauhan O Rodriguez RE Kuntz 2001 Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials Circulation 103 1967 1971 11306525 1:STN:280:DC%2BD3M3kvFWmsw%3D%3D (Pubitemid 32322224)
4. DE Cutlip S Windecker R Mehran A Boam DJ Cohen GA van Es PG Steg MA Morel L Mauri P Vranckx E McFadden A Lansky M Hamon MW Krucoff PW Serruys 2007 Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2344 2351 17470709 10.1161/CIRCULATIONAHA.106.685313 (Pubitemid 46685903)
5. P Diehl C Olivier C Halscheid T Helbing C Bode M Moser 2010 Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes Basic Res Cardiol 105 379 387 19943165 10.1007/s00395-009-0073-8 1:CAS:528:DC%2BC3cXis1yhsbo%3D
6. AL Frelinger 3rd MR Barnard ML Fox AD Michelson 2010 The platelet activity after clopidogrel termination (PACT) study Circ Cardiovasc Interv 3 442 449 20736449 10.1161/CIRCINTERVENTIONS.110.937961 1:CAS:528:DC%2BC3cXhsFaiurzO
7. T Geisler C Zurn R Simonenko M Rapin H Kraibooj A Kilias B Bigalke K Stellos M Schwab AE May C Herdeg M Gawaz 2010 Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions Eur Heart J 31 59 66 19812059 10.1093/eurheartj/ehp402
8. B Hechler Y Zhang A Eckly JP Cazenave C Gachet K Ravid 2003 Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice J Thromb Haemost 1 155 163 12871553 10.1046/j.1538-7836.2003.00003.x 1:CAS:528:DC%2BD3sXpsFyqtbo%3D
9. PM Ho ED Peterson L Wang DJ Magid SD Fihn GC Larsen RA Jesse JS Rumsfeld 2008 Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome JAMA 299 532 539 18252883 10.1001/jama.299.5.532 1:CAS:528:DC%2BD1cXhsFCiu74%3D (Pubitemid 351222546)
10. PM Ho TT Tsai TY Wang SM Shetterly CL Clarke AS Go A Sedrakyan JS Rumsfeld ED Peterson DJ Magid 2010 Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system Circ Cardiovasc Qual Outcomes 3 303 308 20354221 10.1161/CIRCOUTCOMES.109.890707
11. R Hoffmann H Klinker U Adamu M Kelm R Blindt 2009 The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use Clin Res Cardiol 98 549 554 19669824 10.1007/s00392-009-0039-8 1:CAS:528:DC%2BD1MXhtFCgt7jJ
12. I Iakovou T Schmidt E Bonizzoni L Ge GM Sangiorgi G Stankovic F Airoldi A Chieffo M Montorfano M Carlino I Michev N Corvaja C Briguori U Gerckens E Grube A Colombo 2005 Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2126 2130 15870416 10.1001/jama.293.17.2126 1:CAS:528:DC%2BD2MXjvFKiu7w%3D (Pubitemid 40617065)
13. K Ibrahim N Hass S Kolschmann RH Strasser RC Braun-Dullaeus 2008 Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis? Clin Res Cardiol 97 797 800 18663507 10.1007/s00392-008-0679-0 1:STN:280:DC%2BD1cjgvFGhtw%3D%3D
14. A Jeremias B Sylvia J Bridges AJ Kirtane B Bigelow DS Pinto KK Ho DJ Cohen LA Garcia DE Cutlip JP Carrozza Jr 2004 Stent thrombosis after successful sirolimus-eluting stent implantation Circulation 109 1930 1932 15078797 10.1161/01.CIR.0000127105.99982.21 (Pubitemid 38544480)
15. A Johnson N Dovlatova S Heptinstall 2008 Multiple electrode aggregometry and P2Y(12) antagonists Thromb Haemost 99 1127 1129 18521523 1:CAS:528:DC%2BD1cXotVyjsbs%3D (Pubitemid 351810501)
16. FG Kushner M Hand SC Smith Jr SB King 3rd JL Anderson EM Antman SR Bailey ER Bates JC Blankenship DE Casey Jr LA Green JS Hochman AK Jacobs HM Krumholz DA Morrison JP Ornato DL Pearle ED Peterson MA Sloan PL Whitlow, et al. 2009 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 120 2271 2306 19923169 10.1161/CIRCULATIONAHA. 109.192663
17. Mauri L, Kereiakes DJ, Normand SL, Wiviott SD, Cohen DJ, Holmes DR, Bangalore S, Cutlip DE, Pencina M, Massaro JM (2010) Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J 160(6):1035-1041
18. AT Ong EP McFadden E Regar PP de Jaegere RT van Domburg PW Serruys 2005 Late angiographic stent thrombosis (LAST) events with drug-eluting stents J Am Coll Cardiol 45 2088 2092 15963413 10.1016/j.jacc.2005.02.086 1:CAS:528:DC%2BD2MXlt1WhsLg%3D (Pubitemid 40814135)
19. C Oury MJ Kuijpers E Toth-Zsamboki A Bonnefoy S Danloy I Vreys MA Feijge R De Vos J Vermylen JW Heemskerk MF Hoylaerts 2003 Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype Blood 101 3969 3976 12521992 10.1182/blood-2002-10-3215 1:CAS:528:DC%2BD3sXktVGnur4%3D (Pubitemid 36857874)
20. M Pfisterer HP Brunner-La Rocca PT Buser P Rickenbacher P Hunziker C Mueller R Jeger F Bader S Osswald C Kaiser 2006 Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2584 2591 17174201 10.1016/j.jacc.2006.10.026 1:CAS:528:DC%2BD28XhtlaltrrE (Pubitemid 44881238)
21. G Shanker JL Kontos DM Eckman D Wesley-Farrington DC Sane 2006 Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts J Thromb Thrombolysis 22 213 220 17111196 10.1007/s11239-006-9033-4 1:CAS:528:DC%2BD28Xht1yis7vN (Pubitemid 44857783)
22. D Sibbing S Braun S Jawansky W Vogt J Mehilli A Schomig A Kastrati N von Beckerath 2008 Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment Thromb Haemost 99 121 126 18217143 1:CAS:528:DC%2BD1cXhtlWisr4%3D
23. Sibbing D, Morath T, Braun S, Stegherr J, Mehilli J, Vogt W, Schomig A, Kastrati A, von Beckerath N (2010) Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 103(1):151-159
24. D Sibbing J Stegherr S Braun J Mehilli S Schulz M Seyfarth A Kastrati N von Beckerath A Schomig 2009 A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment J Am Coll Cardiol 55 558 565 10.1016/j.jacc.2009.09.038
25. G Tolhurst C Vial C Leon C Gachet RJ Evans MP Mahaut-Smith 2005 Interplay between P2Y(1), P2Y(12), and P2X(1) receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling Blood 106 1644 1651 15914557 10.1182/blood-2005-02-0725 1:CAS:528:DC%2BD2MXps1Ogsb0%3D (Pubitemid 41208577)
26. D Trenk W Hochholzer MF Fromm LE Chialda A Pahl CM Valina C Stratz P Schmiebusch HP Bestehorn HJ Buttner FJ Neumann 2008 Cytochrome P450 2C19 681G > A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents J Am Coll Cardiol 51 1925 1934 18482659 10.1016/j.jacc.2007.12.056 1:CAS:528:DC%2BD1cXlvFOqsLY%3D (Pubitemid 351636443)
27. JW van Werkum AA Heestermans AC Zomer JC Kelder MJ Suttorp BJ Rensing JJ Koolen BR Brueren JH Dambrink RW Hautvast FW Verheugt JM ten Berg 2009 Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry J Am Coll Cardiol 53 1399 1409 19371823 10.1016/j.jacc.2008.12.055
28. AA Weber M Braun T Hohlfeld B Schwippert D Tschope K Schror 2001 Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers Br J Clin Pharmacol 52 333 336 11560568 10.1046/j.0306-5251.2001. 01453.x 1:CAS:528:DC%2BD3MXntFCnsbo%3D (Pubitemid 33796233)
29. JJ Wykrzykowska A Warnholtz P de Jaeger N Curzen KG Oldroyd JP Collet JM Ten Berg T Rademaker D Goedhart J Lissens PP Kint PW Serruys 2009 Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (discontinuation effect of clopidogrel after drug eluting stent): a multicenter, open-label study J Thromb Thrombolysis 28 410 417 19504052 10.1007/s11239-009- 0354-y 1:CAS:528:DC%2BD1MXhtlSlsL7F